Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Details)

v3.19.2
Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Jan. 31, 2019
Jan. 01, 2019
Concentration Risk [Line Items]              
Government grant           $ 1,500  
Right-of-use assets $ 1,277   $ 1,277   $ 0    
Lease liabilities $ 1,327   $ 1,327        
Customer Concentration Risk | Accounts Receivable              
Concentration Risk [Line Items]              
Concentration risk percentage     0.00%   19.00%    
Customer Concentration Risk | Revenue              
Concentration Risk [Line Items]              
Concentration risk percentage 31.00% 0.00% 21.00% 0.00%      
ASU 2016-02              
Concentration Risk [Line Items]              
Right-of-use assets             $ 1,498
Lease liabilities             $ 1,454
Minimum              
Concentration Risk [Line Items]              
Accounts receivable payment terms     30 days        
Maximum              
Concentration Risk [Line Items]              
Accounts receivable payment terms     60 days        
EksoHealth | Minimum              
Concentration Risk [Line Items]              
Accounts receivable payment terms     12 months        
EksoHealth | Maximum              
Concentration Risk [Line Items]              
Accounts receivable payment terms     48 months